GLP-1 Price Guide Compare prices
Safety · June 1, 2026

What to Ask Before Buying Semaglutide Online

Ten questions to ask any online compounded semaglutide provider before enrolling.

Safety & RegulationJune 1, 2026Editorial
Editorial disclosure: GLP-1 Price Guide is an educational health pricing resource. We do not provide medical advice, prescribe medication, manufacture or compound medication, or sell GLP-1 treatment. Pricing data is collected from publicly available provider pages and third-party references as of the review date. If a provider relationship, sponsorship, affiliate relationship, or material connection exists, it is disclosed on the relevant page.
Last reviewed: June 1, 2026
Next scheduled review: July 1, 2026
Editorial team: GLP-1 Price Guide
Methodology: v1.0 pricing framework
  1. What is the maintenance-dose monthly price (not just starter)?
  2. Is there a separate membership fee, or is everything bundled?
  3. Are provider visits, lab review, and shipping included?
  4. Which named pharmacy fills my prescription?
  5. Is the pharmacy a licensed 503A or 503B facility? Can I verify through the State Board?
  6. What is the prescriber's name and license state?
  7. What clinical evaluation is required before prescribing?
  8. What are the cancellation and refund terms?
  9. What happens at refill — does pricing change?
  10. Are there any auto-renewal terms I should know about?

If a provider can't or won't answer any of these clearly, that's a transparency signal.

Sources reviewed

  • Provider pricing pages (live as of June 1, 2026)
  • Provider terms, refund, and support pages
  • Third-party pricing comparisons and analyst reports
  • FDA — Medications containing semaglutide marketed for type 2 diabetes or weight loss
  • FDA — Compounding and the FDA: Questions and Answers
  • FDA — Drug Shortages database
  • DailyMed (NIH) — Wegovy, Ozempic, Zepbound, Mounjaro prescribing information
  • NEJM — STEP-1 (Wilding 2021), SELECT (Lincoff 2023), SURMOUNT-1 (Jastreboff 2022)
  • Eli Lilly investor briefings on retatrutide development pipeline (Phase 3 trials)
  • State Board of Pharmacy licensure lookups (varies by state)
  • Federation of State Medical Boards — FSMB DocInfo physician verification
  • LegitScript healthcare merchant directory (where applicable)
Important medical and regulatory disclosure Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products. They are not the same as Ozempic, Wegovy, Mounjaro, or Zepbound. Compounded medications may be prescribed only when clinically appropriate after review by a licensed medical provider. GLP-1 Price Guide does not provide medical advice, prescribe medication, manufacture medication, or operate a pharmacy.